RE:All this drug needs is a properly designed trial
"preliminary results from an Australian sponsored trial have yet to verify whether the mechanism of RVX-208 action may affect glucose metabolism" and "The preliminary results were not consistent with their hypothesis"... stated another way - Australian trial failed. Nice press release to sugar coat the bad news.
It will be interesting to see what they release if they don't get AZ funding - how can they spin that with more ongoing analysis of Assure and Sustain.